Figure 4From: The chromatin modification by SUMO-2/3 but not SUMO-1 prevents the epigenetic activation of key immune-related genes during Kaposi’s sarcoma associated herpesvirus reactivationTop 10 potential SUMO-2/3 targeting TFs ranking by gene number before KSHV reactivation. bold: transcription factor with evidence of SUMO modification.Back to article page